Annual Total Long Term Liabilities
$949.68 M
+$8.83 M+0.94%
31 December 2023
Summary:
Pacific Biosciences of California annual total long term liabilities is currently $949.68 million, with the most recent change of +$8.83 million (+0.94%) on 31 December 2023. During the last 3 years, it has risen by +$909.69 million (+2274.97%). PACB annual total long term liabilities is now -17.01% below its all-time high of $1.14 billion, reached on 31 December 2021.PACB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$936.93 M
-$1.47 M-0.16%
30 September 2024
Summary:
Pacific Biosciences of California quarterly total long term liabilities is currently $936.93 million, with the most recent change of -$1.47 million (-0.16%) on 30 September 2024. Over the past year, it has dropped by -$13.72 million (-1.44%). PACB quarterly long term liabilities is now -18.12% below its all-time high of $1.14 billion, reached on 31 December 2021.PACB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | -1.4% |
| 3 y3 years | +2275.0% | -17.6% |
| 5 y5 years | +3137.9% | +2010.1% |
PACB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.0% | +2275.0% | -18.1% | +0.3% |
| 5 y | 5 years | -17.0% | +3137.9% | -18.1% | +2243.1% |
| alltime | all time | -17.0% | >+9999.0% | -18.1% | >+9999.0% |
Pacific Biosciences Of California Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $936.93 M(-0.2%) |
| June 2024 | - | $938.40 M(-1.0%) |
| Mar 2024 | - | $947.95 M(-0.2%) |
| Dec 2023 | $949.68 M(+0.9%) | $949.68 M(-0.1%) |
| Sept 2023 | - | $950.65 M(+1.8%) |
| June 2023 | - | $934.22 M(-0.5%) |
| Mar 2023 | - | $938.63 M(-0.2%) |
| Dec 2022 | $940.85 M(-17.8%) | $940.85 M(-15.3%) |
| Sept 2022 | - | $1.11 B(+0.1%) |
| June 2022 | - | $1.11 B(-2.7%) |
| Mar 2022 | - | $1.14 B(-0.3%) |
| Dec 2021 | $1.14 B(+2761.6%) | $1.14 B(+0.6%) |
| Sept 2021 | - | $1.14 B(+20.8%) |
| June 2021 | - | $942.10 M(+0.4%) |
| Mar 2021 | - | $938.60 M(+2247.3%) |
| Dec 2020 | $39.99 M(-8.9%) | $39.99 M(-1.4%) |
| Sept 2020 | - | $40.55 M(-2.0%) |
| June 2020 | - | $41.39 M(-2.3%) |
| Mar 2020 | - | $42.39 M(-3.5%) |
| Dec 2019 | $43.91 M(+49.7%) | $43.91 M(-1.1%) |
| Sept 2019 | - | $44.40 M(-2.1%) |
| June 2019 | - | $45.38 M(-0.6%) |
| Mar 2019 | - | $45.63 M(+55.6%) |
| Dec 2018 | $29.33 M(-0.1%) | $29.33 M(-0.2%) |
| Sept 2018 | - | $29.38 M(+0.2%) |
| June 2018 | - | $29.32 M(+0.2%) |
| Mar 2018 | - | $29.26 M(-0.3%) |
| Dec 2017 | $29.35 M | $29.35 M(+12.0%) |
| Sept 2017 | - | $26.20 M(-0.6%) |
| June 2017 | - | $26.35 M(-14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $30.88 M(+58.8%) |
| Dec 2016 | $19.44 M(+0.3%) | $19.44 M(-2.1%) |
| Sept 2016 | - | $19.85 M(+1.8%) |
| June 2016 | - | $19.49 M(+0.5%) |
| Mar 2016 | - | $19.39 M(0.0%) |
| Dec 2015 | $19.39 M(-48.9%) | $19.39 M(-1.3%) |
| Sept 2015 | - | $19.65 M(-17.8%) |
| June 2015 | - | $23.92 M(-13.1%) |
| Mar 2015 | - | $27.54 M(-27.4%) |
| Dec 2014 | $37.95 M(-14.6%) | $37.95 M(-3.8%) |
| Sept 2014 | - | $39.47 M(-4.3%) |
| June 2014 | - | $41.26 M(-4.1%) |
| Mar 2014 | - | $43.00 M(-3.3%) |
| Dec 2013 | $44.45 M(+699.7%) | $44.45 M(-5.0%) |
| Sept 2013 | - | $46.78 M(+149.0%) |
| June 2013 | - | $18.79 M(-1.7%) |
| Mar 2013 | - | $19.10 M(+243.7%) |
| Dec 2012 | $5.56 M(-25.7%) | $5.56 M(-8.1%) |
| Sept 2012 | - | $6.04 M(-11.1%) |
| June 2012 | - | $6.80 M(-3.4%) |
| Mar 2012 | - | $7.04 M(-5.9%) |
| Dec 2011 | $7.48 M(+48.3%) | $7.48 M(+21.7%) |
| Sept 2011 | - | $6.14 M(-4.4%) |
| June 2011 | - | $6.43 M(+11.7%) |
| Mar 2011 | - | $5.75 M(+14.2%) |
| Dec 2010 | $5.04 M(-98.1%) | $5.04 M(-98.7%) |
| Sept 2010 | - | $380.32 M(+7331.1%) |
| June 2010 | - | $5.12 M(-98.1%) |
| Dec 2009 | $269.80 M(+33.7%) | $269.80 M |
| Dec 2008 | $201.79 M | - |
FAQ
- What is Pacific Biosciences of California annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual total long term liabilities year-on-year change?
- What is Pacific Biosciences of California quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly long term liabilities year-on-year change?
What is Pacific Biosciences of California annual total long term liabilities?
The current annual total long term liabilities of PACB is $949.68 M
What is the all time high annual total long term liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total long term liabilities is $1.14 B
What is Pacific Biosciences of California annual total long term liabilities year-on-year change?
Over the past year, PACB annual total long term liabilities has changed by +$8.83 M (+0.94%)
What is Pacific Biosciences of California quarterly total long term liabilities?
The current quarterly long term liabilities of PACB is $936.93 M
What is the all time high quarterly long term liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total long term liabilities is $1.14 B
What is Pacific Biosciences of California quarterly long term liabilities year-on-year change?
Over the past year, PACB quarterly total long term liabilities has changed by -$13.72 M (-1.44%)